Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J’s Path Forward – An Interview With Alex Gorsky

This article was originally published in The Tan Sheet

Executive Summary

In a conversation shortly before taking the helm at Johnson & Johnson, CEO Gorsky discusses deal strategies, emerging markets, his experience overseeing both the device and pharma businesses and the value of J&J’s consumer health product portfolio.

You may also be interested in...



J&J Picks Outsider With Broad Experience To Lead Consumer Group

Bayer CropScience CEO Sandra Peterson will join Johnson & Johnson Dec. 1 as group worldwide chairman with oversight of consumer companies, IT and global supply chain. Worldwide Consumer Group Chairman Jesse Wu will report to Peterson, who also takes a seat on J&J’s executive committee.

J&J Picks Outsider With Broad Experience To Lead Consumer Group

Bayer CropScience CEO Sandra Peterson will join Johnson & Johnson Dec. 1 as group worldwide chairman with oversight of consumer companies, IT and global supply chain. Worldwide Consumer Group Chairman Jesse Wu will report to Peterson, who also takes a seat on J&J’s executive committee.

J&J Picks Outsider With Broad Experience To Lead Consumer Group

Bayer CropScience CEO Sandra Peterson will join Johnson & Johnson Dec. 1 as group worldwide chairman with oversight of consumer companies, IT and global supply chain. Worldwide Consumer Group Chairman Jesse Wu will report to Peterson, who also takes a seat on J&J’s executive committee.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS105743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel